Organizations Behind Population Control
Funding for immunological contraceptive research is provided by the World Bank, the UN Population Fund, USAID, Rockefeller Foundation, US and Canadian governments, and others. The major research teams include World Health Organization, National Institute of Immunology (India), The Population Council (USA), The Contraceptive Research and Development Program (USA), and the National Institute for Child Health and Development (USA).
World Health Organization
The UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP). Since its inception in 1972, the goal of the UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP) has been to coordinate, promote, conduct, and evaluate research in human reproduction.
When HRP was set up in 1972, the development and assessment of new and improved methods of fertility regulation was established as a major objective, and immunization as a means of regulating fertility was considered a promising area for investigation.
Population Council
The Population Council is the leading developer of long-acting, reversible contraception. Council-developed products include the Copper T intrauterine device (IUD), the levonorgestrel intrauterine system Mirena®, and the implants Jadelle® and Norplant®.
Funding includes the Rockefeller Institute, Gates Foundation, unknown government sources, other private donors around the world, and even some military funding.
In their own words: “The Council plays a unique role by employing a “bench to bedside” approach—whereby scientists identify drugs and delivery systems, conduct preclinical studies and late-stage clinical trials, and work with regulatory authorities to bring new technologies to the market. Our product pipeline includes vaginal rings and contraceptive gels. And we are pursuing new contraceptives for men that use the novel androgen MENT®, a synthetic steroid that resembles testosterone but does not stimulate prostate growth.
United Nations
The March 2009 UN Population Division Policy Brief asked the following question: What would it take to accelerate fertility decline in the least developed countries? The United Nations has long been concerned about population growth around the world. They called for additional investments in family planning, feeling that such expenditures are ‘cost effective because of the strong synergistic effects of longer inter-birth intervals and lower fertility with other development goals.’
Fast population growth, fueled by high fertility, hinders the reduction of poverty and the achievement of other internationally agreed development goals.” (World population monitoring, focusing on the contribution of the Programme of Action of the International Conference on Population and Development to the internationally agreed development goals, including the Millennium Development Goals. Report of the Secretary-General (E/CN.9/2009/3).)
UN Population Division Policy Brief, March 2009
WHO_PoPControlVaccinesDownload